All In MedTech

Device Trial Radar · NCT01372475

Hymovis™ Versus Placebo in Knee Osteoarthritis

A Multi-Centre, Double-Blind, Randomized, Placebo Controlled Study To Evaluate The Safety And Effectiveness Of A New Viscoelastic Hydrogel (Hymovis) In The Treatment Of Knee OA With An Open-Label Extension

Last checked: Nov 20, 2026Latest source record: Apr 8, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

800

Actual

Start

Mar 2011

Primary completion

Nov 2012

Study completion Feb 2013

Sponsor

Lead sponsor
Fidia Farmaceutici s.p.a.Not on our public-company list
Sponsor type
Industry
First posted
Jun 14, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Purpose: The purpose of this study is to demonstrate if the intra-articular injection of a new viscoelastic Hydrogel (Hymovis) is superior to Placebo (phosphate buffered saline \[PBS\] in subjects with symptomatic osteoarthritis of the knee.

Conditions

  • Knee Osteoarthritis

Interventions

  • Hymovis Intra-articular InjectionDevice

    Hymovis Intra-articular injection

  • Phosphate Buffered Saline InjectionProcedure

    Placebo Intra-articular injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Pain sub-scoreTime frame: 26 weeks

Locations

33 sites in 2 countries. Site status is shown where the registry gives one.

  • Achieve Clinical Research, LLC

    Birmingham, Alabama

  • Tucson Orthopaedic Institute

    Tucson, Arizona

  • Core Orthopaedic

    Encinitas, California

30 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.